Dulcolax®
-
Dokumente
-
Transparency
Transparency is an essential cornerstone of trust in the healthcare industry
-
Geog van Husen
Cardiovascular
Presented by Dr. Georg van Husen, Therapy Head Cardiovascular at Boehringer Ingelheim
-
Research & Development
-
Vision
The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
-
Who we are
We are proud to be honored with the international Prix Galien 2018 as an innovation and research leader in the field of Diabetes therapy.
-
BI Office Hours
Who we are
Boehringer Ingelheim invites innovative biomedical start-ups and entrepreneurs to join the next BI Office Hours at the Research Institute of Molecular Pathology (IMP). This is a great opportunity to benefit from BI’s science and business know-how.
-
Haustiere_Katze
Chronic kidney disease in cats
-
Dog_girl
Epilepsy
-
-
Animal Health general
Companion Animals
-
Animal Health general
Equine
-
Animal Health general
Cattle
-
Animal Health general
Swine
-
Our Focus Ambition
-
Our Focus AAI
-
Our Focus Leitbild